3 not yet recruiting, 2 completed, 2 recruiting, 1 active not recruiting. 3 Phase 1, 3 Phase 2, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Recruiting 1 |
| Phase 2 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
| Not applicable | 2 | Active not recruiting 1, Not yet recruiting 1 |
Follow Lymphoma Non-Hodgkin: new trials by email Literature Review of Lymphoma Non-Hodgkin trials Research Report on Lymphoma Non-Hodgkin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin Lymphoma Rituximab, Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisolone (R-CHOP), Epcoritamab, Dexamethasone - Non-Hodgkin's B-cell Lymphoma, Lymphoma Non-Hodgkin | Phase 2 | Not yet recruiting | Carrie Ho, MD | 20 | 2026-11-15 | 2026-10-01 |
| A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies UB-VV400, Rapamycin (sirolimus) - Lymphoma, B Cell, Lymphoma Non-Hodgkin | Phase 1 / Phase 2 | Recruiting | Umoja Biopharma | 274 | 2026-09-01 | 2026-10-09 |
| High-Dose vs Standard Ergocalciferol for Vitamin D Normalization in Aggressive Non-Hodgkin Lymphoma High-Dose Loading Ergocalciferol, Standard Weekly Ergocalciferol - Vitamin D 25-Hydroxylase Deficiency, Lymphoma Non-Hodgkin | Not applicable | Not yet recruiting | Phramongkutklao College of Medicine and Hospital | 52 | 2026-02-01 | 2026-01-26 |
| Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma Non-Hodgkin Lymphoma, Lymphoma Non-Hodgkin | Recruiting | Henry M. Jackson Foundation for the Advancement of Military Medicine | 300 | 2025-05-01 | 2026-09-03 | |
| Study of the Association Between Fatigue Experienced by Patients and the Specific Side Effects of CART Cells, During the First Month After Administration for Non-Hodgkin's Lymphoma Fatigue assessment - Fatigue Symptom, Lymphoma Non-Hodgkin | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 100 | 2025-04-01 | 2025-03-21 | |
| A Manualised Post-Traumatic Growth Intervention For People With Hematological Cancers In Greece A manualised post-traumatic growth intervention for people with hematological cancers - Blood Cancers, Leukemia | Not applicable | Active not recruiting | University of West Attica | 80 | 2024-06-06 | 2026-09-10 |
| A Study of CC-97540, CD19-targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, in Subjects With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma CC-97540 - Lymphoma Non-Hodgkin, Agressive Lymphoma | Phase 1 | Completed | Juno Therapeutics, a Subsidiary of Celgene | 24 | 2020-05-21 | 2024-05-20 |
| Japanese Phase Ib/II Copanlisib in Relapsed, Indolent B-cell NHL Copanlisib (BAY80-6946) - Lymphoma Non-Hodgkin | Phase 1 / Phase 2 | Completed | Bayer | 25 | 2015-04-21 | 2023-01-20 |
Lymphoma, Non-Hodgkin (8) · Lymphoma, B-Cell (4) · Lymphoma (3) · Lymphoma, Large B-Cell, Diffuse (3) · Anxiety Disorders (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Depression (1) · Fatigue (1) · Hematologic Neoplasms (1) · Immunologic Deficiency Syndromes (1) · Leukemia (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Multiple Myeloma (1) · Myelodysplastic Syndromes (1) · Neoplasms (1)
Hemic and Lymphatic Diseases (8) · Immune System Diseases (8) · Immunoproliferative Disorders (8) · Lymphatic Diseases (8) · Lymphoproliferative Disorders (8) · Neoplasms by Histologic Type (8) · Neoplasms (7) · Lymphoma (5) · Pathological Conditions, Signs and Symptoms (2) · Avitaminosis (1) · Behavior (1) · Behavioral Symptoms (1) · Blood Protein Disorders (1) · Bone Marrow Diseases (1) · Cardiovascular Diseases (1)
Blood Specimen Collection (1) · Coatomer Protein (1) · Cyclophosphamide (1) · Dexamethasone (1) · Doxorubicin (1) · Magnetic Resonance Spectroscopy (1) · Mindfulness (1) · Prednisolone (1) · Rituximab (1) · Sirolimus (1) · Surveys and Questionnaires (1) · Vincristine (1) · copanlisib (1)
Assistance Publique - Hôpitaux de Paris (1) · Bayer (1) · Carrie Ho, MD (1) · Henry M. Jackson Foundation for the Advancement of Military Medicine (1) · Juno Therapeutics, a Subsidiary of Celgene (1) · Phramongkutklao College of Medicine and Hospital (1) · Umoja Biopharma (1) · University of West Attica (1)
United States (4) · Canada (1) · Greece (1) · Japan (1) · Thailand (1)
Carrie Ho, MD (1) · Christin Destefano (1) · Luke Walker, MD (1) · Tanapun Thamgrang (1)